Only routine notices since September

Fevertree Drinks (LSE:FEVR) has issued a steady flow of routine announcements since its interim results, most recently a transaction in own shares notice on 10 November 2026, alongside holdings notifications and a director dealing. None changes the trading picture. This article therefore returns to the results for the six months to 30 June 2026, published on 10 September, and focuses on a theme management repeatedly stressed: the shift of the Brand away from dependence on tonic water.

Tonic now just over half of sales

The company (LSE:FEVR) said products other than tonic made up 47% of group sales in the first half, against 39% three years earlier. Globally, tonic Revenue rose 3% while the wider portfolio grew 13%. Ginger Beer, Pink Grapefruit and Mexican Lime Soda were named as the leading flavour platforms, with Ginger Beer described as the standout performer.

In the UK the shift is sharper. Beyond-tonic products accounted for 32% of UK sales, up from 24% three years ago. UK tonic revenue was flat, which the company said outperformed declines in the gin category, while the rest of the range grew 10%. Management linked this to a Marketing campaign promoting the drinks both as mixers and as premium soft drinks, and to expanded pack formats.

Regional growth, headline and underlying

UK revenue rose 3% to £49.5 million, which the company described as a return to growth, helped by a solid off-trade performance, a 1.8 percentage point gain in value share there and favourable summer weather. It called the UK on-trade challenging because of pressure on consumer spending and venue costs.

Europe looks firmer on the surface than underneath. Fever-Tree brand revenue there rose 13% to £49.6 million, or 10% at constant currency, but the company said underlying growth was about 4%, with the rest coming from good performances in France and Switzerland and favourable order phasing. Rest of the world revenue rose 5% at constant currency to £17.6 million despite unfavourable phasing in Canada; Australia, New Zealand and Canada were each in double-digit underlying growth. Group brand revenue rose 8% at constant currency to £183.6 million. The US, where Molson Coors now handles distribution, remained the largest single region, with revenue of £66.9 million in the first half.

Why the mix matters

The Diversification reduces exposure to gin, a category the company itself describes as declining, and opens up non-alcoholic occasions. Management pointed to moderation, premiumisation and longer, lighter drinks as long-term trends, and to new products such as a non-alcoholic Mojito in its ready-to-drink range, a Lemon, Lime and Bitters soft drink in Australia and a flavoured Ginger Beer in France, with further European launches planned next year.

Adjusted EBITDA for the half rose 9% to £20.1 million and the Interim Dividend increased 2% to 6.09 pence. The board said its expectations for 2026 were unchanged and in line with market expectations.

Factors to watch

Order phasing flattered Europe in the first half and held back Canada, so second-half regional growth may look different. Premium soft drinks compete in a crowded market, and the brand's UK success partly reflected weather that may not recur. Market Share figures cited by the company come from third-party retail data covering specific channels. Cash fell to £68.0 million from £130.0 million a year earlier, reflecting buybacks; the company described its Balance Sheet as solid.

What to watch

Fevertree (LSE:FEVR) has not yet announced a date for its full-year trading update. Investors will look for whether European growth holds once phasing reverses, and for any update on Tariff refunds the company began receiving after the half.